SiriusPoint (SPNT) has reorganized its operations into four business areas, combining its North America and International Programs into a single Global P&C Programs division and creating a London Market Specialty unit, while a senior international executive departs.
See our latest analysis for SiriusPoint.
SiriusPoint’s latest reorganization comes as the share price has eased in recent months, with a 30 day share price return decline of 4.99% and a 90 day share price return decline of 9.30%. In contrast, the 1 year total shareholder return of 25.42% and 3 year total shareholder return of very large gain suggest longer term momentum remains stronger.
If this kind of corporate reshaping has you looking beyond a single insurer, it could be a good moment to scan for other opportunities using 20 top founder-led companies
With SiriusPoint trading at $20.38, an indicated intrinsic discount of roughly 43% and a price target of $24, the real question is whether you are seeing mispricing today or whether the market is already banking on future growth.
Most Popular Narrative: 15.1% Undervalued
With SiriusPoint last closing at $20.38 against a narrative fair value of $24, the current setup hinges on how you view future earnings power and the price investors might eventually be willing to pay for it.
SiriusPoint's growing and diversifying platform of MGA partnerships, particularly in international and London markets, as well as its selective approach to retaining more net risk, provides a structural tailwind for both fee-based and underwriting income; the market may be undervaluing this future potential for sustained top line and earnings growth as these relationships mature and scale.
Want to see what kind of revenue path and margin reset need to line up with that higher future earnings multiple? The most followed narrative sets out a clear, numbers driven roadmap that explains why the same business could justify a richer P/E in a few years than it trades on today.
Result: Fair Value of $24 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that roadmap can still be knocked off course if newer MGA partnerships underperform or if profit margins tighten faster than analysts currently model in their forecasts.
Find out about the key risks to this SiriusPoint narrative.
Next Steps
Reading this, you can probably sense there is both excitement and caution around SiriusPoint, so consider acting promptly, reviewing the numbers yourself and weighing the 3 key rewards and 2 important warning signs.
Looking for more investment ideas?
If SiriusPoint has sharpened your focus, do not stop here. Use targeted screeners to uncover other companies that might fit the kind of portfolio you want.
- Spot potential turnaround candidates early by scanning 32 elite penny stocks with strong financials that already show stronger financial underpinnings than many expect from low priced names.
- Zero in on quality at a discount by reviewing 54 high quality undervalued stocks that pair solid fundamentals with valuations implying the market could be overlooking them.
- Prioritize resilience by checking 72 resilient stocks with low risk scores that score well on balance sheet strength and overall risk metrics before headlines catch up.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com